GB0218235D0 - Antibodies - Google Patents

Antibodies

Info

Publication number
GB0218235D0
GB0218235D0 GB0218235A GB0218235A GB0218235D0 GB 0218235 D0 GB0218235 D0 GB 0218235D0 GB 0218235 A GB0218235 A GB 0218235A GB 0218235 A GB0218235 A GB 0218235A GB 0218235 D0 GB0218235 D0 GB 0218235D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0218235A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0218235A priority Critical patent/GB0218235D0/en
Publication of GB0218235D0 publication Critical patent/GB0218235D0/en
Ceased legal-status Critical Current

Links

GB0218235A 2002-08-06 2002-08-06 Antibodies Ceased GB0218235D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0218235A GB0218235D0 (en) 2002-08-06 2002-08-06 Antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0218235A GB0218235D0 (en) 2002-08-06 2002-08-06 Antibodies

Publications (1)

Publication Number Publication Date
GB0218235D0 true GB0218235D0 (en) 2002-09-11

Family

ID=9941820

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0218235A Ceased GB0218235D0 (en) 2002-08-06 2002-08-06 Antibodies

Country Status (1)

Country Link
GB (1) GB0218235D0 (en)

Similar Documents

Publication Publication Date Title
EP1494693A4 (en) Cripto-specific antibodies
PL375405A1 (en) Antibodies
HK1213007A1 (en) Anti-avb6 antibodies v6
EP1616881A4 (en) Anti-mpl antibodies
IL175608A0 (en) Antibodies
PT1599504E (en) Modified antibody
AU2003217912A8 (en) Antibody optimization
EP1432444A4 (en) Anti-a-beta antibodies
HK1074206A1 (en) Anti-trail-r antibodies
GB0228210D0 (en) Single chain antibodies
GB0208331D0 (en) Proteins
GB0209884D0 (en) Proteins
EP1677112A4 (en) Immunoassay
GB0305448D0 (en) Immunoassay
EP1487874A4 (en) Falp proteins
GB0306618D0 (en) Antibody
GB0226878D0 (en) Antibodies
PL376318A1 (en) Protein modification
AU2003270055A8 (en) Neurotransmission-associated proteins
AU2003300785A8 (en) Carbohydrate-associated proteins
GB0218232D0 (en) Antibodies
GB0203018D0 (en) Antibodies
GB0210508D0 (en) Antibodies
GB0218229D0 (en) Antibodies
HK1072381A1 (en) Cripto-specific antibodies cripto-specific

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)